ArticleScientific reports2026
Human papillomavirus vaccination: knowledge, acceptance, and barriers among medical students. An Egyptian multicenter cross sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) infection is a major public health concern and a leading cause of cervical cancer worldwide. Despite the availability of effective vaccines, awareness and vaccine acceptance remain limited in many developing countries. This study aimed to assess awareness, acceptance, barriers, and determinants of HPV vaccination among medical students in Egypt. A web-based multicentre cross-sectional study was conducted among undergraduate medical students from governmental, national, and private medical faculties across Egypt using a non-probability sampling approach (convenience and snowball sampling). Data were collected using a validated structured questionnaire. A total of 601 students participated in the study. 31.4% were unaware that HPV is available for both males and females, and half of them expressed negative attitudes and concerns regarding the novelty (44%), safety (56%), efficacy (59%), and cost of the vaccine (51.7%). Nearly half (48.3%) of them were unaware that the "HPV vaccine" is available in Egypt. Seventy-three students (12.1%) received the vaccine, and among vaccinated participants, 39 were males. In addition, 44.3% of students reported hesitancy toward HPV vaccination, while 58.9% indicated willingness to receive the vaccine if it was provided free of charge. Family history of cervical cancer, total knowledge, and attitude scores were significant predictors of participants' HPV vaccine uptake (p < 0.05). Nearly half of the participants had not taken the vaccine because they were not sexually active or they lacked knowledge. Unfortunately, about one-third of the participants didn't take the vaccine because of cultural and parental objections. Male participants were less likely to recommend the vaccine to others. In spite of being medical students, their knowledge and attitudes were less than expected, giving an idea about the public situation. Findings underscore the importance of educational campaigns to raise knowledge and change faulty beliefs, focusing on the target groups and their parents. Also, the national health authorities should allocate resources to make the HPV vaccine available, accessible, and affordable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.